Social network crowdsourcing supports medical research

In recent weeks The Wall Street Journal reported that the results of a new clinical trial into the effects of lithium on Lou Gehrig’s disease demonstrate the potential for social networks to be used in the recruitment and collation of patient data.

A total of 596 patients took part in the observational study by health social network, PatientsLikeMe, which concluded that lithium does not slow down the progression of Lou Gehrig’s disease.

PatientsLikeMe used a questionnaire and bespoke tool to collect the data and during the study, patients were able to visit the website and see how other participants were getting on in real time.

Through the use of a social network, the process of enrolling patients was sped up and the cost of drugs and recruiting patients was avoided, given that participants approached their own doctors for prescriptions.

It sounds marvellously promising, but Harvard Medical School ALS researcher, Merit Cudkowicz, has queried the danger in placing 100% trust in a social network clinical trial, highlighting that it wouldn’t pick up minor benefits lithium may have and it would be wrong to completely disregard the drug on the social study’s basis alone.

According to The Globe and Mail, a recent report published by Canadian researchers in science journal, Nature, also shows the power social media can have over the spread of a medical theory before it’s even been proven. Italian doctor, Paulo Zamboni’s unproven theory that MS is actually caused by malformed neck veins and can subsequently be treated has been heavily pedalled on social networks by MS patients. Health institutes may now be forced to change their health research spending as a result of patients having read word-of-mouth evidence via social networking sites.

There is clearly a place for social media as an aid to – but not a complete replacement for – medical research. But, it won’t work without medical experts and thought-leaders joining in the conversations to balance emotions with science; and without informative, reliable and optimised content filling the search engines.

Enhanced by Zemanta

Latest Posts

A new marketing order Why the teams adapting best are rebuilding around demand, clearer proof and marketing that works as one joined-up system Maxine Ashbrook, Marketing Director at Fujitsu UK got to the point faster than most marketing commentary does. She did not try to outwork the…
Read More
£38m pipeline in 12 weeks. That was the outcome of a programme for a large tech B2B brand built on a fairly unfashionable idea. Instead of filling social and event content with the messages the brand most wanted to push, we built it around the questions buyers were genuinely trying…
Read More
Whether it’s for consumer products or B2B lead driving, Reddit has found its footing as a key platform for reaching audiences far and wide. And the best part is – it’s cheap to advertise on. 121m daily active users in Q4 of 2025 (up 19% on the year before) means…
Read More